
|Articles|December 1, 1996
The American Journal of Managed Care
- November/December 1996
- Volume 2
- Issue 11
A Pharmacoeconomic Assessment of Torsemide in the Treatment of Congestive Heart Failure
Author(s)Alan H. Heaton, PharmD, Jeffrey P. Trotter, MM
Advertisement
Articles in this issue
about 29 years ago
The Year in Reviewabout 29 years ago
Childhood Immunizations: Beyond HEDISabout 29 years ago
Implementation of a Clinical Pathway for Cesarean Sectionabout 29 years ago
Six HMOs in Search of a Study: Comments on Two Papers by Horn et alabout 29 years ago
The Economic and Health-Related Quality of Life Impact of EpilepsyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
5














































